COVID Unrest, Health Sector Deep Freeze Hits Chinese Biotechs Hard

Some Already Responding To Challenges

 
• By Brian Yang
  
Beijing relies on mass PCR testing to contain virus spreading in Nov. 2022
China's COVID Zero policies, which rely on mass testing like this in Beijing, are hitting biotechs hard • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip